Search

Home > New FDA Approvals > 118 - Blinatumomab given accelerated approval; FDA grants Orphan Drug Designation to CYP-001 for GVHD; FDA to consider what 'healthy' means.
Podcast: New FDA Approvals
Episode:

118 - Blinatumomab given accelerated approval; FDA grants Orphan Drug Designation to CYP-001 for GVHD; FDA to consider what 'healthy' means.
Category: Science & Medicine
Duration: 00:12:08
Publish Date: 2018-03-30 06:00:00
Description:

March 30, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:46 Accelerated approval given to Blincyto (blinatumomab) to treat adults and children with B-cell precursor (ALL) who are in remission but still have minimal residual disease. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm603151.htm

4:12 FDA grants Orphan Drug Designation to Cynata’s Lead Cymerus™ MSC Product, CYP-001 https://globenewswire.com/news-release/2018/03/28/1454619/0/en/FDA-Grants-Orphan-Drug-Designation-to-Cynata-s-Lead-Cymerus-MSC-Product-CYP-001.html 

6:25 FDA to consider what 'healthy' means and other claims food companies can make https://www.cnbc.com/2018/03/29/fda-to-consider-updating-health-claims-food-manufacturers-can-make.html

The next 6 week course "Everything You Need to Know to Start Your Freelance Medical Writing Business" will begin on Monday April 9th, 2018. More details at 6weekcourse.com

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0